InsurTech SPACs face nail-biting redemption votes
  • X
  • LinkedIn
  • Show more sharing options
  • Copy Link URLCopied!
  • Print
  • X
  • LinkedIn
© 2024 Insider International Limited, company number 15236286, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian Group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

InsurTech SPACs face nail-biting redemption votes

Hippo qomplx doma logos NYC 2.jpg

A trio of InsurTech special purpose acquisition company (SPAC) deals now face the prospect of investor redemptions, as a crucial equity market indicator points to muted support for the transactions among investors.

Hippo, Doma and Qomplx all agreed to merge with SPACs in early March, at a time when institutional investors were enthusiastically backing such deals at pumped up valuations.

Enter your e-mail to claim a free trial:

Uncover exclusive insights tailored for insurance leaders

    • Stay Informed: Access exclusive industry insights
    • Gain a competitive advantage: Hear first about tactical developments
    • Make better decisions: Understand market dynamics in crucial lines of business
Gift this article